Two of the state’s leading developers were among the honorees last week as the Meadowlands Area YMCA marked a fundraising milestone for its food pantry program.
Turnkey, high-end life sciences space remains in high demand in New Jersey, creating an opportunity for owners of the state’s few remaining legacy pharmaceutical campuses or those that can find other ways to create new space without building speculatively.
Johnson & Johnson’s highly anticipated consumer health spinoff is leasing 290,000 square feet of office and laboratory space in Summit, in a deal that will activate a campus recently acquired by Onyx Equities.
The state’s commercial real estate industry turned out last week at the new-look One Gateway Center in Newark, the host of the annual Big Climb event, helping to raise more than $58,000 in support of The Leukemia & Lymphoma Society.
Our April edition highlights the ongoing demand from established pharmaceutical firms, startups and a growing pool of international users for high-quality, turnkey laboratory and manufacturing space in New Jersey — and the opportunity for landlords that can provide it.
Three Gateway Center, one of four buildings in Newark’s revamped Gateway complex and the home of more than 500,000 square feet of office space, is on the market for sale.
Merck & Co. has sold its 108-acre campus in Kenilworth to a joint venture of Onyx Equities and Machine Investment Group, with plans to lease back the nearly 2 million-square-foot complex while it relocates in phases over the next several years.
State officials have picked Russo Development, Onyx Equities and Terminal Construction to spearhead a project that would reshape NJ Transit’s busy Metropark station in Woodbridge.
Market experts say large, high-profile office deals are likely still to come in New Jersey, despite the push for hybrid schedules and lingering questions about the return to work.
